SCHEMBL2332604

SCHEMBL2332604

CC(CC(N)=O)N(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27555648 0.78 CHRNB2 (0.40)
SCHEMBL9512873 0.78 CHRNB2 (0.43)
SCHEMBL652699 0.77 CHRNB2 (0.42)
SCHEMBL27852738 0.77 CHRNB2 (0.39)
SCHEMBL103866 0.76
SCHEMBL1615800 0.76 CHRNB2 (0.58)
SCHEMBL105805 0.76
SCHEMBL6236654 0.76 TDP1 (0.39)
SCHEMBL8903486 0.76
SCHEMBL16846175 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101304978-B Quinazoline derivative as multi-component inhibitor, pharmaceutical composition and application HANMI PHARM IND CO LTD 2012-12-26 CN disclosed
EP-2358397-A2 5' and 2' bis-substituted nucleosides and oligomeric compounds prepared therefrom Isis Pharmaceuticals, Inc. (US) 2011-08-24 EP disclosed
EP-2358398-A2 OLIGOMERIC COMPOUNDS AND METHODS Isis Pharmaceuticals, Inc. (US) 2011-08-24 EP disclosed
WO-2010048549-A2 5' AND 2' BIS-SUBSTITUTED NUCLEOSIDES AND OLIGOMERIC COMPOUNDS PREPARED THEREFROM ISIS PHARMACEUTICALS, INC. (US) 2010-04-29 WO disclosed
WO-2010048585-A2 OLIGOMERIC COMPOUNDS AND METHODS ISIS PHARMACEUTICALS, INC. (US) 2010-04-29 WO disclosed
CN-101304978-A Quinazoline derivatives as multiplex inhibitors and process for their preparation HANMI PHARM IND CO LTD (KR) 2008-11-12 CN disclosed
WO-1984004302-A1 SUBSTITUTED PICOLINIC ACIDS, PROCESSES FOR THEIR PREPARATION, THEIR USE AND MEDICAMENTS CONTAINING THEM BYK GULDEN LOMBERG CHEM FAB (DE) 1984-11-08 WO disclosed